DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Intravascular Ultrasound (IVUS) Imaging During Transvenous Lead Extraction

Not Applicable

Completed

Conditions: Device Malfunction
ICD
Pacemaker Lead Dysfunction

Interventions: Device: IVUS Imaging

First Posted Date: 2019-08-14

Last Posted Date: 2021-12-27

Lead Sponsor: University of Chicago

Target Recruit Count: 28

Registration Number: NCT04055740

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Effects of Drugs on Responses to Brain and Emotional Processes

Early Phase 1

Completed

Conditions: Autism Spectrum Disorder
Healthy

Interventions: Drug: MDMA
Drug: Placebo oral tablet

First Posted Date: 2019-08-12

Last Posted Date: 2024-11-25

Lead Sponsor: University of Chicago

Target Recruit Count: 22

Registration Number: NCT04053036

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Thirty Million Words-Early Childhood Educator (TMW-ECE)

Not Applicable

Completed

Conditions: Language Development

Interventions: Behavioral: TMW ECE Curriculum

First Posted Date: 2019-07-22

Last Posted Date: 2020-04-09

Lead Sponsor: University of Chicago

Target Recruit Count: 432

Registration Number: NCT04027673

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Phase 2

Recruiting

Conditions: B Cell Lymphoma
Diffuse Large B Cell Lymphoma
Lymphoma
High-grade B-cell Lymphoma
Lymphoma, B-Cell

Interventions: Drug: Pembrolizumab
Drug: R-CHOP Protocol

First Posted Date: 2019-06-21

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 51

Registration Number: NCT03995147

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)

Phase 2

Active, not recruiting

Conditions: Diffuse Large B Cell Lymphoma
Lymphoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2019-06-19

Last Posted Date: 2024-07-11

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT03990961

Locations: 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States

Tracking Depression Symptoms With a Health Chatbot

Not Applicable

Completed

Conditions: Depression, Unipolar
Depression, Postpartum

Interventions: Device: Chatbot Intervention

First Posted Date: 2019-06-19

Last Posted Date: 2022-05-12

Lead Sponsor: University of Chicago

Target Recruit Count: 31

Registration Number: NCT03990389

Locations: 🇺🇸
NorthShore University HealthSystem, Skokie, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Behavior Brain Responses

Early Phase 1

Completed

Conditions: Alcohol Drinking
Central Nervous System Depression
Drinking Behavior
Physiological Effects of Drugs

Interventions: Other: Placebo
Drug: Ethanol

First Posted Date: 2019-05-28

Last Posted Date: 2025-01-31

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT03964350

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

The Effects of Therapy Dogs on Child Biology and Behavior

Not Applicable

Completed

Conditions: Stress Reaction
Behavior, Social

Interventions: Behavioral: Therapy Dog
Behavioral: Stuffed Toy Dog
Behavioral: 5 Minute Puppy Video

First Posted Date: 2019-05-14

Last Posted Date: 2024-05-09

Lead Sponsor: University of Chicago

Target Recruit Count: 188

Registration Number: NCT03949569

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

De-Escalation Therapy for Human Papillomavirus Negative Disease

Phase 2

Completed

Conditions: Human Papilloma Virus
Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Head and Neck
HPV-Related Squamous Cell Carcinoma
HNSCC

Interventions: Drug: Carboplatin
Drug: Paclitaxel
Radiation: Radiation
Drug: Nivolumab
Drug: Hydroxyurea Pill
Drug: 5-fluorouracil
Drug: Filgrastim Injection
Drug: Cisplatin

First Posted Date: 2019-05-10

Last Posted Date: 2025-05-11

Lead Sponsor: University of Chicago

Target Recruit Count: 35

Registration Number: NCT03944915

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Mood Effects of Serotonin Agonists Extended

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Serotonin agonist - 13ug
Drug: Serotonin agonist - 26ug

First Posted Date: 2019-05-02

Last Posted Date: 2023-11-29

Lead Sponsor: University of Chicago

Target Recruit Count: 56

Registration Number: NCT03934710

Locations: 🇺🇸
Matthew Bona, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy